Literature DB >> 7545739

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.

R E Tato1, A Frank, A Hernanz.   

Abstract

Tau protein concentrations were measured in the CSF of 23 patients with dementia of the Alzheimer type (DAT), 36 patients with multi-infarct dementia (MID), and 23 control subjects. Tau protein concentrations were significantly higher in patients with DAT than in controls (P < 0.001) and patients with MID (P < 0.001). A significantly positive correlation between CSF tau protein and glucose concentrations (r = 0.79, P < 0.001) and evolution of disease (r = 0.47, P < 0.05), and a negative correlation with Folstein's mental state examination test (r = -0.73, P < 0.001) were found in patients with DAT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545739      PMCID: PMC486030          DOI: 10.1136/jnnp.59.3.280

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection.

Authors:  M Mercken; M Vandermeeren; U Lübke; J Six; J Boons; E Vanmechelen; A Van de Voorde; J Gheuens
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

2.  Is it time to reassess the pathological criteria for a diagnosis of Alzheimer disease?

Authors:  D C Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  1993       Impact factor: 2.703

3.  Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; C R Harrington; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

4.  Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

Authors:  C Bancher; H Braak; P Fischer; K A Jellinger
Journal:  Neurosci Lett       Date:  1993-11-12       Impact factor: 3.046

5.  Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.

Authors:  T Sakurada; I Alufuzoff; B Winblad; A Nordberg
Journal:  Brain Res       Date:  1990-06-25       Impact factor: 3.252

6.  Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein.

Authors:  S Khatoon; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

7.  A sandwich enzyme immunoassay for detecting and measuring Alzheimer's disease--associated proteins in human brain tissue.

Authors:  H A Ghanbari; T Kozuk; B E Miller; S Riesing
Journal:  J Clin Lab Anal       Date:  1990       Impact factor: 2.352

8.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.

Authors:  P V Arriagada; J H Growdon; E T Hedley-Whyte; B T Hyman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

9.  Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type.

Authors:  M Martinez; A Frank; A Hernanz
Journal:  J Neuroimmunol       Date:  1993 Nov-Dec       Impact factor: 3.478

10.  Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

Authors:  M Vandermeeren; M Mercken; E Vanmechelen; J Six; A van de Voorde; J J Martin; P Cras
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

View more
  18 in total

1.  A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test.

Authors:  K Ghanbari; H A Ghanbari
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 2.  Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.

Authors:  Garrett S Gibbons; Virginia M Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 3.  CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.

Authors:  Hanna Rosenmann
Journal:  J Mol Neurosci       Date:  2011-11-05       Impact factor: 3.444

4.  Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.

Authors:  Zhicheng Chen; David Mengel; Ashvini Keshavan; Robert A Rissman; Andrew Billinton; Michael Perkinton; Jennifer Percival-Alwyn; Aaron Schultz; Michael Properzi; Keith Johnson; Dennis J Selkoe; Reisa A Sperling; Purvish Patel; Henrik Zetterberg; Douglas Galasko; Jonathan M Schott; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2018-11-09       Impact factor: 21.566

5.  Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease.

Authors:  Susanna Levy; Matthew McConville; Glorie A Lazaro; Paul Averback
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

6.  Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

Authors:  N Rösler; I Wichart; K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Authors:  N Andreasen; E Vanmechelen; A Van de Voorde; P Davidsson; C Hesse; S Tarvonen; I Räihä; L Sourander; B Winblad; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

8.  Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies.

Authors:  Celeste M Karch; Amanda T Jeng; Alison M Goate
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

9.  Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker.

Authors:  H Ghanbari; K Ghanbari; I Beheshti; M Munzar; A Vasauskas; P Averback
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 10.  Biomarkers of Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Anne M Fagan; David M Holtzman
Journal:  Neurobiol Dis       Date:  2008-10-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.